Combining MRI-Targeted, Systematic Biopsy Appears Best for PCa Detection
In a study, 8.8% of clinically relevant prostate cancers detected by systematic biopsy were missed by MRI-targeted biopsy.
Biopsy
AI System Can Detect, Grade Cancer in Prostate Needle Biopsy
AUCs were 0.997, 0.986 for distinguishing between benign, malignant biopsy cores, respectively.
AI Program May Aid in Pathologic Evaluation of Breast Biopsies
Computer-based automated approach promising for differentiating ductal carcinoma in situ from atypia
Misdiagnosed Wart Highlights Importance of Obtaining Biopsy of Changing Skin Lesions
Patients who present with irregular or growing amelanocytic lesions on the acral surface of the hands or feet should undergo biopsy promptly.
Second Opinions from Multidisciplinary Breast Tumor Board Are Beneficial
A retrospective, observational study investigated the impact of obtaining a second opinion of a breast cancer diagnosis from a multidisciplinary tumor board.
18F-FDG PET/CT Accurately Identifies Bone Marrow Involvement in Pediatric Hodgkin’s Lymphoma
Researchers conducted a retrospective study to assess 18F-FDG PET/CT vs bone marrow biopsy to detect bone marrow involvement among pediatric patients with Hodgkin lymphoma.
Benefit of Lymph Node Biopsies May Be Limited in Microinvasive Breast Cancer
Researchers sought to determine the benefit of managing microinvasive breast cancer similarly to invasive tumors in a retrospective study.
Liquid Biopsy Results Could Guide, Expedite Clinical Trial Enrollment
Researchers assessed the use of cfDNA-based liquid biopsy to guide and expedite clinical trial enrollment for patients with with metastatic urothelial carcinoma.
Active Surveillance, Repeat Biopsies Not Linked to Post Prostatectomy Complications
Rates of erectile dysfunction and urinary incontinence at 1, 2, and 3 years after radical surgery are not higher among men who have multiple prostate biopsies while on active surveillance for prostate cancer.
Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
Whole-exome sequencing of tumor biopsies explain low response rate to immunotherapy in metastatic melanoma.
-
Loading...
-
Loading...
Next post in Melanoma
